Ginkgo Bioworks today announced that management will be participating in two investor conferences in May.
BOSTON, May 15, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that management will be participating in two investor conferences in May.
Further details, webcast links, and a replay of the presentations, fireside chats, and panels, if available, will be posted on the company’s investor relations website at investors.ginkgobioworks.com. About Ginkgo Bioworks Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn. Ginkgo Bioworks Contacts: INVESTOR CONTACT: MEDIA CONTACT: View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-to-participate-in-two-conferences-in-may-302145465.html SOURCE Ginkgo Bioworks | ||
Company Codes: NYSE:DNA |